Trevor Resnick, MD: Treating Epilepsy By Blending Technology, Genetics, and Pharmacologics


The pediatric epileptologist at Nicklaus Children’s Hospital spoke about the future of epilepsy and shared which studies of the condition that he’s been keeping an eye on.

“The biggest change in pediatric epilepsy has been the evolution of genetic mutations. It’s really understanding the genetic mutations and types of epilepsy.”

Patients with epilepsy are often refractory to the available antiepileptic medications, making them an incredibly difficult population to treat. Adding in that a large number of these patients are pediatric patients only clouds the situation.

To try to solve this, a blend of technology, genetics, and medicine has begun to occur, with the future of treatment relying on a combination of the 3 to really improve outcomes for these patients. For Trevor Resnick, MD, the field’s gains in increasing the understanding of the genetic variations between types of epilepsies has primed the future for this combination approach.

To discuss this further, as well as to provide some insight into the clinical trials and studies in these areas that he’s been keeping an eye on and what they mean for the field, the pediatric epileptologist at Nicklaus Children’s Hospital spoke with NeurologyLive in an interview.

Related Videos
Jessica Ailani, MD
Frederic Schaper, MD, PhD
Jaime Imitol, MD
Jason M. Davies, MD, PhD
Carolyn Bernstein, MD
Prashanth Rajarajan, MD, PhD
Mandy Alhajj, DO, James Dolbow, DO & Neel Fotedar, MD
Riley Bove, MD
© 2024 MJH Life Sciences

All rights reserved.